BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Large Growth in Short Interest

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a significant growth in short interest in January. As of January 30th, there was short interest totaling 15,325 shares, a growth of 267.9% from the January 15th total of 4,166 shares. Based on an average trading volume of 60,328 shares, the short-interest ratio is currently 0.3 days. Based on an average trading volume of 60,328 shares, the short-interest ratio is currently 0.3 days.

BriaCell Therapeutics Stock Down 33.3%

NASDAQ:BCTXW opened at $0.00 on Friday. BriaCell Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.25. The stock’s 50 day moving average price is $0.03 and its two-hundred day moving average price is $0.04.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on the development of novel immunotherapeutic treatments for breast cancer and other solid tumors. The company’s research strategy centers on harnessing the body’s immune system to recognize and attack cancer cells, with an emphasis on off-the-shelf allogeneic platforms that can be readily administered without the need for patient-specific manufacturing.

The company’s lead candidate, Bria-IMT, is derived from a human breast tumor cell line engineered to express immune-stimulatory molecules designed to trigger both innate and adaptive anti-tumor responses.